Congress

Cost-effectiveness of tablets of Posaconazole compared to oral Fluconazole or Itraconazole in the prevention of invasive fungal diseases among high-risk neutropenic patients with either acute myelogenous leukemia or myelodysplastic syndrome in Spain


Skip to content
Privacy Summary

This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful.